spacer
home > ebr > summer 2003 > making the remarkable routine
PUBLICATIONS
European Biopharmaceutical Review

Making the Remarkable Routine

Mass spectrometry (MS) has become one of the most ubiquitous analytical techniques in use today. It represents a powerful tool in the study of all substances because it provides more information about the composition and structure of a substance from a smaller amount of sample than any other analytical technique.

Of all the MS techniques currently available, fourier transform ion cyclotron resonance mass spectrometry (FT-ICR MS) is arguably the most powerful. It offers 10-100 times higher mass resolution, mass resolving power and mass accuracy than any other mass analysis technique. Alternatively, viewed only as a separation device, ultrahigh-resolution FT-ICR MS offers more than 100 times higher peak capacity than the most effective wet chemical separation methods. This makes it possible to analyse complex mixtures with no prior chromatography.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Professor Alan Marshall, National High Magnetic Field Laboratory at Florida State University, USA and Dr Alan Street, Oxford Instruments Superconductivity, at Oxford Instruments, UK

Professor Alan G Marshall received his BA in Chemistry from Northwestern University and PhD in Physical Chemistry from Stanford University. Following faculty positions at University of British Columbia and Ohio State University, he moved to Florida State University in 1993, where he is Kasha Professor of Chemistry and Director of the Ion Cyclotron Resonance Program at the National High Magnetic Field Laboratory. He is best known for his co-invention and continuing leading development of fourier transform ion cyclotron resonance (FT-ICR) mass spectrometry.

His recognitions include Fellow in the American Physical Society and the American Association for the Advancement of Science; three national awards from the American Chemical Society; and awards from the Spectroscopy Society of Pittsburgh, the American Society for Mass Spectrometry and the International Society for Mass Spectrometry. In addition Professor Marshall is widely published.


Dr Alan Street gained a degree in Physics from the University of Wales and a DPhil from the University of York. His working life has focused on the development and exploitation of technology, having started in 1975 with GEC at their Hirst Research Centre in Wembley.

He moved to Marconi Elliot Avionics at Boreham Wood and then on to Sperry Gyroscope in Bracknell to join a team developing a new navigational technology based on laser gyroscopes. Joining Oxford Instruments Superconductivity in 1982, Alan is now Technical Director and Deputy Managing Director.


spacer
Professor Alan G Marshall
spacer
spacer
spacer
Dr Alan Street
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical, a biotechnology company, announce a strategic partnership. Under the terms of the collaboration, WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production, providing integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services from API to drug product.
More info >>

White Papers

Contemporary Issues in Comparator Trial Supply

Clinigen CTS

As trial design and execution becomes ever-more complex, initiatives to adapt, increase efficiency and control costs without compromising quality become paramount. Here, Clinigen CTS covers the broad issues and summarises the responses our industry is making in this increasingly demanding landscape.
More info >>

 
Industry Events

World Vaccine Congress Europe

28-31 October 2019, Barcelona, Spain

The 20th annual World Vaccine Congress Europe is taking place 28-31 Oct in Barcelona. It’s the biggest and most established European vaccine event with over 250 speakers, 700+ senior vaccine attendees, hundreds of networking hours. It cover key topics across the complete vaccine value chain bringing together: • Government • big pharma • big biotech • SME Biotech • academia and the wider service provider community and their partners to discuss scientific, clinical and strategic advances and opportunities. The event has already confirmed over 200 speakers from Human Vaccine Project, OECD, CEPI, European Commission, FDA, WHO, OECD, NIH, GSK and many more… There is a Super Early Bird offer available – Find Out More www.terrapinn.com/WVCEU/EBR
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement